The board of directors of China Biotech Services Holdings Limited announced that Mr. Ho Fung Shan Bob has tendered his resignation as an independent non-executive Director with effect from 31 December 2018 due to his other business commitments which require more of his dedication. Upon his resignation, Mr. Bob Ho has also ceased to be a member of each of the audit committee, the nomination committee and the remuneration committee of the Company. The Board announced that with effect from 31 December 2018, Dr. Ho Ivan Chun Kit has been appointed as an independent non-executive Director and a member of each of the audit committee, the nomination committee and the remuneration committee of the Company. Dr. Ivan Ho is currently a Partner in cardiac electrophysiology at Los Angeles Cardiology Associate and an Assistant Health Sciences Clinical Professor of Medicine at University of California Los Angeles David Geffen School of Medicine since 2010. He is the Medical Director of the Complex Ablation Program at the Good Samaritan Hospital, and the assistant director of Atrial Fibrillation Research of Cedars-Sinai Medical Center Health Institute. He is also the director of Cardiac Electrophysiology Program and Laboratory at Garfield Medical Center. Professionally, he is a fellow of Heart Rhythm Society and the America College of Cardiology. Starting in February 2019, he will join the faculty of Keck School of Medicine at University of Southern California where he will be an Associate Professor of Clinical Medicine, and the Director of Clinical Electrophysiology of Keck Medical Center at University of Southern California.